Table 2.
Paired plasma and PBMC samples from Senegalese HIV-2 seropositive infected participants
| Plasma Sample | PBMC Sample | ||||||
|---|---|---|---|---|---|---|---|
| HIV Ag/Ab Combo# | Multispot^ | HIV-2 RNA | HIV-2 TNA | HIV-1 TNA | |||
| Specimen ID | Group | Results (S/CO+) | Interpretation | Results (c/mL) | Results | DC~ | Results |
| H2A32 | A | 5.89 | HIV NEG | TND* | Detected | 4.99 | Not detected |
| H2A76 | A | 22.07 | HIV-2 (wk) | TND | Detected | 8.24 | Not detected |
| H2A24 | A | 54.78 | HIV-2-after 1:10 | 32 | Detected | 8.86 | Not detected |
| H2A67 | NT$ | 66.66 | HIV-2 (wk) | TND | Detected | 1.07 | Not detected |
| H2A72 | B | 99.79 | HIV-2 | TND | Detected | 7.24 | Not detected |
| H2A25 | A | 122.55 | HIV-2 | <10, detected | Detected | 5.73 | NT$ |
| H2A66 | NT$ | 123.75 | HIV-2 | TND | Detected | 6.17 | Not detected |
| H2A64 | A | 139.49 | HIV-2-after 1:10 | TND | Detected | 6.92 | Not detected |
| H2A26 | A | 142.28 | HIV-2 | TND | Detected | 5.03 | NT$ |
| H2A53 | A | 149.89 | HIV-2-after 1:100 | TND | Detected | 6.39 | Not detected |
| H2A84 | NT$ | 157.64 | HIV-2 | TND | Detected | 3.00 | Not detected |
| H2A14 | A | 160.84 | HIV-2-after 1:100 | n/a | Detected | 8.34 | Not detected |
| H2A78 | NT$ | 165.91 | HIV-2 | TND | Detected | 6.17 | Not detected |
| H2A3 | A | 168.28 | HIV-2-after 1:100 | 115 | Detected | 7.97 | Not detected |
| H2A30 | A | 179.93 | HIV-2-after 1:100 | TND | Detected | 9.39 | Not detected |
| H2A10 | A | 186.91 | HIV-2 | TND | Detected | 6.58 | Not detected |
| H2A34 | A | 189.62 | HIV-2 | <10, detected | Detected | 5.32 | Not detected |
| H2A38 | NT$ | 192.39 | HIV-2-after 1:100 | <10, detected | Detected | 5.59 | Not detected |
| H2A74 | A | 192.51 | HIV-2 | TND | Detected | 9.08 | Not detected |
| H2A62 | A | 196.98 | HIV-2 | TND | Detected | 4.76 | Not detected |
| H2A57 | A | 205.59 | HIV-2 | TND | Detected | 6.66 | Not detected |
| H2A77 | A | 206.43 | HIV-2-after 1:10 | TND | Detected | 8.46 | Not detected |
| H2A22 | A | 207.58 | HIV-2-after 1:10 | TND | Detected | 5.15 | Not detected |
| H2A55 | A | 219.28 | HIV-2 | TND | Detected | 8.67 | Not detected |
| H2A6 | A | 222.62 | HIV-2 | TND | Detected | 6.51 | Not detected |
| H2A33 | A | 223.00 | HIV-2-after 1:100 | TND | Detected | 6.32 | Not detected |
| H2A20 | A | 225.10 | HIV-2 | 16 | Detected | 3.92 | Not detected |
| H2A82 | NT$ | 234.44 | HIV-2 | TND | Detected | 8.25 | Not detected |
| H2A9 | A | 234.58 | HIV-2 | TND | Detected | 4.72 | Not detected |
| H2A31 | A | 293.67 | HIV-2 | TND | Detected | 4.17 | Not detected |
#
Abbott ARCHITECT HIV Ag/Ab Combo assay
^
Multispot results interpreted without dilution are stated without further description. Samples determined to be HIV-2 seropositive after 1:10 or 1:100 dilutions as stated. Wk, weak positive.
$
NT, Not tested;
+
S/CO, Signal-to-cutoff ratio;
*
TND, Target not detected; ~DC, Delta Cycle.